Recapitulating the clinical scenario of BRCA‐associated pancreatic cancer in pre‐clinical models
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31292
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. BRCA‐associated PDAC comprises a clinically relevant subtype. A portion of these patients are highly susceptible to DNA damaging therapeutics, however, responses are heterogeneous and… read more here.
Keywords: brca associated; hrd genome; treatment;